Alzheimer's disease (AD) is a chronic age‐related neurodegenerative brain disorder
characterized by the impairment of memory accompanied by worsening of thinking ability of …

Mental illnesses are one of the most relevant health problems today, among which
Alzheimer's disease (AD) stands out. This is a severe disease that entails different …

Abstract Alzheimer's disease (AD), the main dementia type accounting for over 70% of the
entire dementia population, progressive decline in memory and executive function. AD …

Berberine, a naturally occurring compound, possesses an interesting multipotent
pharmacological profile potentially applicable for Alzheimer's disease (AD) treatment. In this …

Background: Alzheimer's Disease (AD) is a complicated neurodegenerative disorder with a
multifaceted pathogenesis. AD, characterized by gradual memory loss, falling in language …

Alzheimer's disease (AD) is a neurodegenerative disease that is characterized as the main
dementia in the elderly. Eighteen pyrazolines were synthesized and evaluated for their …

Alzheimer's disease (AD) is a gradually growing irreversible illness of the brain that almost
affects every fifth person (aged> 80 years) in the world. World Health Organization (WHO) …

Aim: Cholinesterase inhibitors and radical scavengers have been recognized as powerful
symptomatic anti-Alzheimer's disease agents. Hence, the present study aimed to develop …

Alzheimer's disease (AD) is a neurodegenerative disorder and the leading cause of
dementia worldwide. It is characterized by a progressive decline in cholinergic …

Alzheimer's disease (AD) is a neurodegenerative disorder mostly influencing the elderly,
and causes death due to dementia. The main pathogenic feature connected with the …